Press Releases

Date Title and Summary Additional Formats
Toggle Summary Evoke Pharma to Present Additional GIMOTI Healthcare Utilization Data Focused on Gastroparesis Care Insights in Women at 2024 Digestive Disease Week (DDW) Conference
Evoke commercial booth located at site #737 SOLANA BEACH, Calif. , May 16, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc.   (NASDAQ: EVOK), a specialty pharmaceutical company focused primarily on treatments for gastrointestinal (GI) diseases with an emphasis on GIMOTI ®  (metoclopramide) nasal spray,
View HTML
Toggle Summary Evoke Pharma Reports Commercial Strategy Progress & Positive Momentum for GIMOTI
Expanded State Medicaid Access for GIMOTI Achieved highest ever monthly GIMOTI prescription fills in May 2024 Promoted former VP of Finance, Mark Kowieski to Chief Financial Officer SOLANA BEACH, Calif. , June 17, 2024 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc.
View HTML